ATE412426T2 - Vakzination in einer dosis mit i mycoplasma hyopneumoniae /i - Google Patents

Vakzination in einer dosis mit i mycoplasma hyopneumoniae /i Download PDF

Info

Publication number
ATE412426T2
ATE412426T2 AT02735755T AT02735755T ATE412426T2 AT E412426 T2 ATE412426 T2 AT E412426T2 AT 02735755 T AT02735755 T AT 02735755T AT 02735755 T AT02735755 T AT 02735755T AT E412426 T2 ATE412426 T2 AT E412426T2
Authority
AT
Austria
Prior art keywords
vaccination
dose
mycoplasma hyopneumoniae
hyopneumoniae
mycoplasma
Prior art date
Application number
AT02735755T
Other languages
English (en)
Inventor
Robin Lee Keich
Lisa Grace Sabbadini
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23168589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE412426(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE412426T2 publication Critical patent/ATE412426T2/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02735755T 2001-07-02 2002-06-07 Vakzination in einer dosis mit i mycoplasma hyopneumoniae /i ATE412426T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30263601P 2001-07-02 2001-07-02

Publications (1)

Publication Number Publication Date
ATE412426T2 true ATE412426T2 (de) 2008-11-15

Family

ID=23168589

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02735755T ATE412426T2 (de) 2001-07-02 2002-06-07 Vakzination in einer dosis mit i mycoplasma hyopneumoniae /i

Country Status (42)

Country Link
US (3) US6846477B2 (de)
EP (3) EP2842569B1 (de)
JP (1) JP2005515162A (de)
KR (1) KR20040030785A (de)
CN (3) CN1551781B (de)
AP (1) AP2003002937A0 (de)
AR (1) AR034678A1 (de)
AT (1) ATE412426T2 (de)
AU (1) AU2002309109B2 (de)
BG (1) BG66481B1 (de)
BR (1) BR0210804A (de)
CA (1) CA2451626C (de)
CY (1) CY1108749T1 (de)
CZ (1) CZ305781B6 (de)
DE (1) DE60229666D1 (de)
DK (3) DK2027873T3 (de)
DO (1) DOP2002000431A (de)
EA (1) EA009901B1 (de)
ES (3) ES2550458T3 (de)
GT (1) GT200200138A (de)
HK (1) HK1207584A1 (de)
HR (1) HRP20031079A2 (de)
HU (1) HU230246B1 (de)
IL (1) IL159349A0 (de)
IS (1) IS7076A (de)
MA (1) MA27047A1 (de)
MX (1) MXPA03011599A (de)
NO (1) NO342654B1 (de)
NZ (1) NZ530106A (de)
OA (1) OA12638A (de)
PA (1) PA8549701A1 (de)
PE (1) PE20030285A1 (de)
PL (1) PL209773B1 (de)
PT (3) PT2842569T (de)
SK (1) SK288010B6 (de)
TN (1) TNSN03155A1 (de)
TW (1) TWI329514B (de)
UA (1) UA78707C2 (de)
UY (1) UY27366A1 (de)
WO (1) WO2003003941A2 (de)
YU (1) YU102203A (de)
ZA (1) ZA200309698B (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
WO2006056841A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Multiple-strain mycoplasma hyopneumoniae vaccines
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
ES2814473T3 (es) 2005-12-29 2021-03-29 Boehringer Ingelheim Animal Health Usa Inc Composiciones inmunogénicas de PCV2 multivalentes y métodos para producir dichas composiciones
CA2635430A1 (en) 2005-12-29 2007-08-23 Boehringer Ingelheim Vetmedica, Inc. Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs
AU2007222016A1 (en) * 2006-03-03 2007-09-13 Merial Limited Mycoplasma hyopneumoniae vaccine
EP2099927A4 (de) * 2006-11-22 2010-05-05 Boehringer Ingelheim Vetmed Verfahren zur reduzierung von mit schweine-circovirus assoziierten krankheitsausbrüchen
EP2859900A1 (de) * 2006-12-11 2015-04-15 Boehringer Ingelheim Vetmedica, Inc. Wirksames Verfahren zur Behandlung von Infektionen mit dem porcinen Circovirus und Lawsonia intracellularis
DK2094872T4 (da) 2006-12-15 2020-05-18 Boehringer Ingelheim Animal Health Usa Inc Behandling af anti-PCV2-antistofseropositive svin med PCV2-antigen
EP1941903A1 (de) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxe und Behandlung von PRDC
EP1958644A1 (de) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Vorbeugung und Behandlung von subklinischer PCVD
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
KR101225304B1 (ko) * 2007-11-06 2013-01-22 와이어쓰 엘엘씨 마이코플라스마 하이오뉴모니아에 비독성 항원보강된 살아있는 백신
EP2231182A4 (de) * 2007-12-31 2012-08-22 Boehringer Ingelheim Vetmed Pcv2-orf2-virusähnliche partikel mit fremdaminosäureinsertion
CN101236206B (zh) * 2008-01-17 2014-10-15 中国兽医药品监察所 一种猪肺炎支原体重组抗原elisa检测试剂盒
CN101980720A (zh) * 2008-01-23 2011-02-23 贝林格尔.英格海姆维特梅迪卡有限公司 Pcv2猪肺炎支原体致免疫组合物及其制备方法
US8444989B1 (en) * 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
HUE043493T2 (hu) 2008-06-27 2019-08-28 Zoetis Services Llc Új adjuváns készítmények
CA2764424C (en) 2009-06-04 2019-12-31 National Institute Of Advanced Industrial Science And Technology Vaccine for mycoplasma infection
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
JP5865350B2 (ja) 2010-05-11 2016-02-17 インターベット インターナショナル ベー． フェー． 母系由来の抗体の存在下での投与に適したマイコプラズマ・ハイオニュ−モニエに対するワクチン
EP2598165B1 (de) * 2010-07-26 2017-09-20 Qu Biologics Inc Immunogene entzündungshemmende zusammensetzungen
US8546149B2 (en) 2010-08-27 2013-10-01 Intervet Inc. Potency test for vaccine formulations
HUE028877T2 (en) * 2010-08-27 2017-01-30 Intervet Int Bv Test of biological activity of vaccine formulation
WO2013131565A1 (en) * 2012-03-07 2013-09-12 Ceva Sante Animale Novel veterinary vaccine
HRP20180607T1 (hr) 2011-06-10 2019-04-05 Oregon Health & Science University Glikoproteini i rekombinantni vektori cmv
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
CN104981252B (zh) 2012-12-28 2019-06-18 勃林格殷格翰动物保健有限公司 包含支原体抗原的免疫原性组合物
PT2938747T (pt) 2012-12-28 2019-08-01 Boehringer Ingelheim Vetmedica Gmbh Método de preparação de uma vacina de micoplasma
EP3733691A1 (de) * 2013-02-05 2020-11-04 Agricultural Technology Research Institute Anti-mycoplasma spp. subunit-impfstoff
CN104338125A (zh) * 2013-07-29 2015-02-11 普莱柯生物工程股份有限公司 一种猪肺炎支原体抗原在预防和治疗猪呼吸道疾病综合征方面的应用
EP3049105B1 (de) 2013-09-19 2020-12-30 Moredun Research Institute Impfstoff
KR102409183B1 (ko) 2013-10-02 2022-06-15 베링거 인겔하임 애니멀 헬스 유에스에이 인크. Ｐｃｖ2 ｏｒｆ2 단백질 변이체 및 이로 이루어진 바이러스 유사 입자
JP6434017B2 (ja) 2013-11-21 2018-12-05 アグリカルチュラル テクノロジー リサーチ インスティテュート マイコプラズマ属菌種の感染を予防する組成物
CN105012948B (zh) * 2014-04-18 2019-07-30 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
CN104248753B (zh) * 2014-05-15 2017-07-28 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
BR102014014727B1 (pt) * 2014-06-16 2018-04-03 Ouro Fino Saúde Animal Ltda COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, GENE SINTÉTICO CODIFICANTE DO COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, COMPOSIÇÃO ANTIGÊNICA, PROCESSO DE OBTENÇÃO DE UM COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae
US9814769B2 (en) 2014-09-30 2017-11-14 Qatar University Vaccines against pathogenic Escherichia coli and methods of using the same
SI3244920T1 (sl) 2015-01-16 2023-09-29 The United States of America, represented by The Secretary of Agriculture, United States Department of Agriculture Cepivo proti slinavki in parkljevki
KR20160099223A (ko) * 2015-02-12 2016-08-22 강원대학교산학협력단 마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
US10519199B2 (en) * 2016-08-12 2019-12-31 Innovac Vaccine composition comprising recombinant protein for preventing swine Mycoplasma infection
RU2668799C1 (ru) * 2017-09-08 2018-10-02 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp.
CN108101969A (zh) * 2017-11-13 2018-06-01 南京大爻网络科技有限公司 一种与猪支原体肺炎相关的抗原及其应用
RU2695679C1 (ru) * 2018-09-11 2019-07-25 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp.
RU2759427C2 (ru) * 2019-07-08 2021-11-12 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp
CN117305192A (zh) * 2023-12-01 2023-12-29 北京瑞阳瑞泰生物科技有限公司 一种猪肺炎支原体rt02株、疫苗组合物及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252328A (en) * 1987-03-26 1993-10-12 Martin Marietta Energy Systems, Inc. Mycoplasma hyopneumoniae antigen and uses therefor
EP0283840A3 (de) * 1987-03-26 1989-08-09 Ml Technology Ventures, L.P. Mycoplasma hyopneuminiae-Antigen und seine Vewendungen
ES2058237T3 (es) 1987-09-18 1994-11-01 Akzo Nv Metodo para la preparacion de una vacuna para combatir la infeccion mycoplasmica en aves de corral.
FI924428A7 (fi) 1990-04-02 1992-10-01 Synergen Inc Polypeptidejä, jotka ovat hyödyllisiä eläinten mykoplasmainfektioiden diagnoosissa ja hoidossa
DE69128361T3 (de) 1990-05-29 2006-04-13 Wyeth Holdings Corp. Impfstoff gegen die pneumonie bei schweinen und verfahren zu seiner herstellung
WO1994007531A1 (en) * 1992-09-28 1994-04-14 Pfizer Inc Method of enhancing cell mediated immune responses
US6113916A (en) * 1990-05-29 2000-09-05 American Cyanamid Company Method of enhancing cell mediated immune responses
US5565205A (en) 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
EP0475185A1 (de) 1990-08-27 1992-03-18 Nippon Flour Mills Co., Ltd. DNA's, die für ein Oberflächenantigen von Mychoplasma hyopneumoniae kodidieren, DNA Fragmente für Primer, rekombinante antigene Peptide und diagnostische Methode für Mycoplasma Pneumoniae vom Schwein unter Nutzung derselben
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5530874A (en) 1993-02-02 1996-06-25 3Com Corporation Network adapter with an indication signal mask and an interrupt signal mask
WO1995009870A1 (en) 1993-10-07 1995-04-13 Iowa State University Research Foundation, Inc. Characterization of mycoplasma hyopneumoniae adhesins
EP1820512B1 (de) 1994-05-10 2013-07-03 Boehringer Ingelheim Vetmedica, Inc. Verbesserter modifizierter BRSV-Lebendimpfstoff
US5788962A (en) 1995-01-17 1998-08-04 The Curators Of The University Of Missouri DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures
AUPN178995A0 (en) * 1995-03-16 1995-04-13 University Of Melbourne, The Antigen composition
US6440408B2 (en) 1996-09-30 2002-08-27 University Of Arkansas Method of treatment
EP0846468B1 (de) 1996-12-05 2004-06-09 Akzo Nobel N.V. Nicht-virulentes Mycoplasma synoviae und Impfstoffe desselben
EP1034004A1 (de) 1997-11-26 2000-09-13 Iowa State University Research Foundation, Inc. Rekombinantes mycoplasma hyponeumoniae vakzin
AU6128900A (en) * 1999-09-29 2001-04-05 Pfizer Products Inc. Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs

Also Published As

Publication number Publication date
PA8549701A1 (es) 2003-01-24
ES2550458T3 (es) 2015-11-10
BG66481B1 (bg) 2015-02-27
MXPA03011599A (es) 2005-03-07
EP2027873B1 (de) 2015-09-09
DK1474067T4 (en) 2017-10-16
TWI329514B (en) 2010-09-01
PT2842569T (pt) 2019-06-17
EP2842569B1 (de) 2019-04-10
EP2027873B8 (de) 2015-11-11
USRE44399E1 (en) 2013-07-30
EP1474067A4 (de) 2005-08-10
CA2451626A1 (en) 2003-01-16
CN102872456A (zh) 2013-01-16
EA009901B1 (ru) 2008-04-28
NO20035762L (no) 2004-02-02
HK1207584A1 (en) 2016-02-05
CA2451626C (en) 2011-05-31
NZ530106A (en) 2007-06-29
OA12638A (en) 2006-06-15
SK288010B6 (sk) 2012-10-02
AU2002309109B2 (en) 2007-12-13
IL159349A0 (en) 2004-06-01
HUP0400434A2 (en) 2007-08-28
MA27047A1 (fr) 2004-12-20
BR0210804A (pt) 2005-05-03
EP2842569A1 (de) 2015-03-04
HK1180224A1 (zh) 2013-10-18
IS7076A (is) 2003-12-15
PT2027873E (pt) 2015-11-03
US20030109473A1 (en) 2003-06-12
CY1108749T1 (el) 2014-04-09
WO2003003941A3 (en) 2004-07-29
ES2312580T5 (es) 2017-12-11
HK1068250A1 (en) 2005-04-29
PT1474067E (pt) 2008-11-14
HU230246B1 (hu) 2015-11-30
AR034678A1 (es) 2004-03-03
UA78707C2 (en) 2007-04-25
JP2005515162A (ja) 2005-05-26
HK1134900A1 (zh) 2010-05-20
BG108546A (bg) 2005-02-28
ES2312580T3 (es) 2009-03-01
UY27366A1 (es) 2003-04-30
GT200200138A (es) 2003-05-15
DK2842569T3 (da) 2019-05-20
SK15792003A3 (sk) 2005-09-08
CN101524532B (zh) 2014-03-19
DK2027873T3 (en) 2015-11-09
YU102203A (sh) 2006-05-25
CN101524532A (zh) 2009-09-09
DK1474067T3 (da) 2008-12-08
NO342654B1 (no) 2018-06-25
KR20040030785A (ko) 2004-04-09
CN1551781A (zh) 2004-12-01
EP1474067A2 (de) 2004-11-10
TNSN03155A1 (fr) 2005-12-23
US6846477B2 (en) 2005-01-25
CN102872456B (zh) 2016-01-20
CN1551781B (zh) 2013-01-02
PE20030285A1 (es) 2003-03-27
CZ305781B6 (cs) 2016-03-16
ES2729579T3 (es) 2019-11-04
US20050013823A1 (en) 2005-01-20
DE60229666D1 (de) 2008-12-11
EP1474067B1 (de) 2008-10-29
EP2027873A1 (de) 2009-02-25
HRP20031079A2 (en) 2005-10-31
ZA200309698B (en) 2014-04-30
WO2003003941A2 (en) 2003-01-16
CZ20033466A3 (cs) 2005-06-15
EP1474067B2 (de) 2017-08-16
PL373367A1 (en) 2005-08-22
DOP2002000431A (es) 2003-01-15
EA200301323A1 (ru) 2005-06-30
AP2003002937A0 (en) 2003-12-31
PL209773B1 (pl) 2011-10-31

Similar Documents

Publication Publication Date Title
ATE412426T2 (de) Vakzination in einer dosis mit i mycoplasma hyopneumoniae /i
DE60127994D1 (de) VERBESSERTE i MYCOPLASMA HYOPNEUMONIAE /i BACTERIN VAKZINE
NO20023674L (no) Regulerbar stol
ATE553776T1 (de) Multivalente impfstoffzusammensetzung
DE60219513D1 (de) Sauerstoffbefeuerter zirkulierender wirbelschichtdampferzeuger
NO20034683D0 (no) Intradermal vaksineinnretning
ATE533506T1 (de) Impfstoff gegen das fortpflanzungs- und atmungssyndrom bei rindern
DK1296715T3 (da) Multivalent vaccinesammensætning
ZA200410153B (en) Improved combine vaccine against mycoplasma hyopneumoniae and porcine viruses
DE60317419D1 (de) C-bogenröntgengerät mit Antikollisionsmittel
DE60139936D1 (de) Graben-mosfet mit doppelt diffundiertem body-profil
DE60307725T8 (de) Katheter mit mehreren Leitungen
ATE406929T1 (de) Schreibstiftartige injektionsvorrichtung mit dosiseinstellhülse
DE60230951D1 (de) Röntgen ct gerät
DE60118008D1 (de) Pharmazeutische zusammensetzungen mit amlodipinmaleat
DE60128005D1 (de) Glucosamin oder mannosamin in kombination mit trehalose gegen gelenksversagen
DE60130237D1 (de) Lasertherapiegerät
DE60113889D1 (de) Projektionsgerät mit Kühlgerät
DE60238111D1 (de) Viszeralfettmesser mit tonometer
NO20030423D0 (no) Temperatursensitiv levende vaksine mot Mycoplasma hyopneumoniae
ATE387204T1 (de) Zusammensetzung mit induzierendem kathartischen effekt
NO20003763D0 (no) Regulerbar stol
DE50213496D1 (de) Gerät, das eine ionisierende Strahlung erzeugt
NO20044090L (no) Substituert 3-fenyl-5-alkoksy-1,3,4-oksadiazol-24neJr, fremstilling derav og anvendelse i medikamenter
NO20011711D0 (no) Stol

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1474067

Country of ref document: EP